Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 23351618)

1.

NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials.

Brown S, Simpson DM, Moyle G, Brew BJ, Schifitto G, Larbalestier N, Orkin C, Fisher M, Vanhove GF, Tobias JK.

AIDS Res Ther. 2013 Jan 28;10(1):5. doi: 10.1186/1742-6405-10-5.

2.

NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: results of a 52-week open-label study.

Simpson DM, Brown S, Tobias JK, Vanhove GF; NGX-4010 C107 Study Group.

Clin J Pain. 2014 Feb;30(2):134-42. doi: 10.1097/AJP.0b013e318287a32f.

PMID:
23446088
3.

A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy.

Clifford DB, Simpson DM, Brown S, Moyle G, Brew BJ, Conway B, Tobias JK, Vanhove GF; NGX-4010 C119 Study Group.

J Acquir Immune Defic Syndr. 2012 Feb 1;59(2):126-33. doi: 10.1097/QAI.0b013e31823e31f7.

PMID:
22067661
4.

Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy.

Simpson DM, Brown S, Tobias J; NGX-4010 C107 Study Group.

Neurology. 2008 Jun 10;70(24):2305-13. doi: 10.1212/01.wnl.0000314647.35825.9c.

PMID:
18541884
5.

Tolerability of NGX-4010, a capsaicin 8% patch, in conjunction with three topical anesthetic formulations for the treatment of neuropathic pain.

Webster LR, Peppin JF, Murphy FT, Tobias JK, Vanhove GF.

J Pain Res. 2012;5:7-13. doi: 10.2147/JPR.S25272. Epub 2012 Jan 20.

7.

An open-label pilot study of high-concentration capsaicin patch in painful HIV neuropathy.

Simpson DM, Estanislao L, Brown SJ, Sampson J.

J Pain Symptom Manage. 2008 Mar;35(3):299-306. Epub 2007 Oct 23.

PMID:
17959343
8.

Tolerability of NGX-4010, a capsaicin 8% dermal patch, following pretreatment with lidocaine 2.5%/prilocaine 2.5% cream in patients with post-herpetic neuralgia.

Webster LR, Nunez M, Tark MD, Dunteman ED, Lu B, Tobias JK, Vanhove GF.

BMC Anesthesiol. 2011 Dec 19;11:25. doi: 10.1186/1471-2253-11-25.

9.

Tolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic pain.

Peppin JF, Majors K, Webster LR, Simpson DM, Tobias JK, Vanhove GF.

J Pain Res. 2011;4:385-92. doi: 10.2147/JPR.S22954. Epub 2011 Nov 14.

10.

Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain.

Simpson DM, Gazda S, Brown S, Webster LR, Lu SP, Tobias JK, Vanhove GF; NGX-4010 C118 Study Group.

J Pain Symptom Manage. 2010 Jun;39(6):1053-64. doi: 10.1016/j.jpainsymman.2009.11.316.

PMID:
20538187
11.

NGX-4010, a capsaicin 8% dermal patch, administered alone or in combination with systemic neuropathic pain medications, reduces pain in patients with postherpetic neuralgia.

Irving G, Backonja M, Rauck R, Webster LR, Tobias JK, Vanhove GF.

Clin J Pain. 2012 Feb;28(2):101-7. doi: 10.1097/AJP.0b013e318227403d.

PMID:
21753727
12.

NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study.

Backonja M, Wallace MS, Blonsky ER, Cutler BJ, Malan P Jr, Rauck R, Tobias J; NGX-4010 C116 Study Group.

Lancet Neurol. 2008 Dec;7(12):1106-12. doi: 10.1016/S1474-4422(08)70228-X. Epub 2008 Oct 30. Erratum in: Lancet Neurol. 2009 Jan;8(1):31.

PMID:
18977178
13.

NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension.

Backonja MM, Malan TP, Vanhove GF, Tobias JK; C102/106 Study Group.

Pain Med. 2010 Apr;11(4):600-8. doi: 10.1111/j.1526-4637.2009.00793.x. Epub 2010 Jan 22.

PMID:
20113411
14.

Efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic pain.

Webster LR, Peppin JF, Murphy FT, Lu B, Tobias JK, Vanhove GF.

Diabetes Res Clin Pract. 2011 Aug;93(2):187-97. doi: 10.1016/j.diabres.2011.04.010. Epub 2011 May 25.

PMID:
21612836
15.

A multicenter, randomized, double-blind, controlled dose finding study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.

Webster LR, Malan TP, Tuchman MM, Mollen MD, Tobias JK, Vanhove GF.

J Pain. 2010 Oct;11(10):972-82. doi: 10.1016/j.jpain.2010.01.270. Epub 2010 Jul 24.

PMID:
20655809
16.

NGX-4010, a high-concentration capsaicin dermal patch for lasting relief of peripheral neuropathic pain.

Noto C, Pappagallo M, Szallasi A.

Curr Opin Investig Drugs. 2009 Jul;10(7):702-10.

PMID:
19579176
17.

Capsaicin dermal patch: in non-diabetic peripheral neuropathic pain.

McCormack PL.

Drugs. 2010 Oct 1;70(14):1831-42. doi: 10.2165/11206050-000000000-00000. Review.

PMID:
20836576
18.

A randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteers.

Kennedy WR, Vanhove GF, Lu SP, Tobias J, Bley KR, Walk D, Wendelschafer-Crabb G, Simone DA, Selim MM.

J Pain. 2010 Jun;11(6):579-87. doi: 10.1016/j.jpain.2009.09.019. Epub 2010 Apr 18.

PMID:
20400377
19.

Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: a Phase III, multicenter, randomized, double-blind, placebo-controlled study conducted over 5 days.

Riff DS, Duckor S, Gottlieb I, Diamond E, Soulier S, Raymond G, Boesing SE.

Clin Ther. 2009 Oct;31(10):2072-85. doi: 10.1016/j.clinthera.2009.09.011.

PMID:
19922878
20.

Pharmacokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic pain.

Babbar S, Marier JF, Mouksassi MS, Beliveau M, Vanhove GF, Chanda S, Bley K.

Ther Drug Monit. 2009 Aug;31(4):502-10. doi: 10.1097/FTD.0b013e3181a8b200.

PMID:
19494795
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk